Q3 FY2026 · ended Sep 30, 2026 · Revenue $206.69M, -7.9% YoY · Filed Nov 2, 2026
Inspire Medical Systems, Inc. (INSP) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In Q3 of fiscal 2026, the quarter ended Sep 30, 2026, it reported revenue of $206.7 million and a net loss of $24.4 million. Free cash flow was $38.9 million. As of Sep 30, 2026 it held $453.1 million in cash and investments and $28.6 million in total debt.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- INSP (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Golden Valley, MN
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1609550
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q3 FY2026 Sep 30, 2026 |
Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $206.7M | $200.6M | $204.6M | $269.1M | $224.5M |
| Operating income | -$28.7M | -$514,000 | -$1.1M | $46.1M | $9.6M |
| Net income | -$24.4M | $314,000 | -$11.3M | $136.1M | $9.9M |
| Diluted EPS | -$0.84 | $0.01 | -$0.39 | $4.66 | $0.34 |
| Operating cash flow | $46.4M | $23.2M | $12.8M | $52.5M | $68.5M |
| Free cash flow | $38.9M | $14.1M | $3.1M | $41.8M | $58.1M |
| Total assets | $953.0M | $926.0M | $911.4M | $907.3M | $807.7M |
| Total liabilities | $126.1M | $100.4M | $119.0M | $126.2M | $141.3M |
| Stockholders' equity | $826.9M | $825.6M | $792.3M | $781.2M | $666.5M |
| Cash and investments | $453.1M | $415.2M | $399.7M | $404.6M | $410.9M |
| Total debt | $28.6M | $29.1M | $29.6M | $32.2M | $32.6M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 2, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 2, 2026 | Nov 2, 2026 |
| 10-Q | Quarterly report | Aug 3, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 3, 2026 | Aug 3, 2026 |
| 8-K |
Current report
Officer or director change
|
Jul 24, 2026 | Jul 20, 2026 |
| 8-K |
Current report
Officer or director change
|
Jul 22, 2026 | Jul 16, 2026 |
All 897 Inspire Medical Systems, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.